.webp)
News
Marc P. Bernegger's interview with NewZapiens
14.03.2025
NewZapiens
Our co-founder, Marc P. Bernegger, recently sat down with New Zapiens for an insightful interview to share his journey—from pioneering in the internet and crypto sectors to launching Maximon, aiming to bridge the gap between scientific research and business in the health and longevity sector.
Maximon published a Research Paper in Frontiers
26.11.2024
Frontiers
Read Maximon's Comprehensive Review with the title: "Climbing the longevity pyramid: overview of evidence-driven healthcare prevention strategies for human longevity" which dives into the innovative field of longevity medicine and introduces the “Longevity Pyramid,” a framework designed to guide interventions that promote healthy aging.
Ayun offers a long life subscription
20.06.2024.
Bilanz
After a few delays, the time has almost come. Ayun's longevity clinic, which has been announced for some time, will open its doors in Zurich at the beginning of July. Initially for a limited number of early bookers. It is now also clear how much the services, which are intended to ensure a longer, healthy lifespan, will cost.
Avea Life is growing rapidly and is already profitable
27.06.2024.
Bilanz
The Zug-based start-up Avea Life is surfing the longevity wave at a decent speed. "We are growing at 300 to 400 percent a year," says Duri Granziol, one of the four company founders. Avea Life has been on the market for two and a half years with potentially life-extending food supplements, and now the expansion is really gaining momentum.
Longevity Is More Than the Promise of Eternal Life
04.06.2024.
finews.ch
Demographics is destiny: People are getting older. Dr. Tobias Reichmuth, Dr. Dr. Elisabeth Roider, and Marc P. Bernegger have developed a unique investment approach called «Maximon» from the desire to stay healthy for a long time. Their longevity clinic «Ayun» will soon open in the heart of Zurich's banking district. A meeting with the three longevity entrepreneurs.
Longevity medicine, a growing field
29.05.2024.
Swiss Medical Journal
Longevity medicine is a rapidly growing, interdisciplinary field that combines general prevention approaches with personalized analyses and interventions and shifts the focus from “sick care” to “health care.” The goal is to extend the healthy lifespan of the individual.
Longevity as the biggest investment opportunity of the century
03.04.2024.
finews.ch
In January, a guest article on finews.com critically addressed the topic of longevity, that is, investments in extending the healthy lifespan of people. The opposite position is now taken by Tobias Reichmuth, partner at the Zug-based longevity investor Maximon. In his opinion, it represents one of the greatest opportunities both medically and financially.
“Longevity” doctors reveal what is important for healthy aging
08.03.2024.
FOCUS Online
What does longevity medicine want? FOCUS spoke online about this with two specialists: Elisabeth Roider, a dermatologist trained at Harvard Medical School, and Leonie Bode, who completed her specialist training in internal medicine in Switzerland.
Lowering the Bar to Invest in Longevity
07.03.2024.
Lifespan.io
Maximon, Marcuard Heritage and GenTwo have announced the launch of a new longevity-related investment opportunity. Their proposal allows professional investors to get access to Maximon’s portfolio of longevity companies via an actively managed certificate (AMC).
Maximon lowers the bar for European longevity investors
05.03.2024.
Longevity.Technology
Swiss longevity company builder Maximon today unveiled a new investment opportunity designed to allow more professional investors in Europe to invest in longevity ventures. Partnering with wealth management firm Marcuard Heritage and fintech company GenTwo, Maximon is responding to demand from investors to improve access to its Longevity Co-Investment Fund (LCIF).
Marcuard Heritage, GenTwo and Maximon introduce an innovative and new longevity investment opportunity accessible to professional investors
04.03.2024.
Maximon
Based on many requests from investors, Marcuard Heritage, one of Switzerland’s leading wealth managers, launched an investment vehicle in the form of an actively managed certificate (AMC) with the support of GenTwo, a Swiss fintech company, to get access to Maximon’s Longevity Co-Investment Fund.
Living 100 years with health: what is the “health span”, the new horizon of longevity
12.02.2024.
La Nacion
“Longevity could become the biggest industry of the future, since everyone is interested in having a healthy, happy and perhaps even longer life,” says Marc P. Bernegger, founding partner of Maximon, a Swiss company that supports and finances the creation of companies focused on longevity. With four companies in the industry in his portfolio, including Avea and Biolytica, he has just announced that he has raised the investment volume to $33 million.
German Menopause Startup Frieda Health Raises €2.5M in Pre-Seed Funding
20.11.2023.
Femtech Insider
Berlin-based femtech startup Frieda Health has secured EUR 2.5 million in pre-seed funding from the Maximon Longevity Co-Investment Fund, an investor and company builder specializing in the longevity sector. This investment will support Frieda Health’s ongoing development of a digital health platform focused on women’s health, particularly for those aged 45 and above, during menopause.
A Longevity Center for Zurich: Eternal life is now available to buy
18.11.2023
NZZ am Sonntag
The country's first longevity center will be opening in Zurich. Investors around the world are currently pumping huge amounts of money into the latest megatrend, longevity. The prospect of a long, healthy life is based on solid science – at least most of the time.
Storm on longevity products: Avea's sales soar in China
15.11.2023.
Startupticker.ch
Avea, the provider of innovative premium longevity solutions has generated more than $180’000 in revenues within 24 hours of entering the Chinese market and $250’000 in one week. Thorough planning and tailoring the products to the customer fueled the positive launch.
The Fourth Edition of the Longevity Investors Conference, Held in Gstaad (Switzerland), Unites Visionary Scientists, Industry Titans and Investors for Unprecedented Collaboration
06.11.2023.
Yahoo! Finance
The two full day event, Longevity Investors Conference, held in Gstaad, featured a diverse array of speakers, including leading scientists, venture capitalists, and entrepreneurs, who shared their insights on breakthroughs in longevity. Several high level investors committed millions of dollars to be brought to the industry.
Five simple things you can do to live a healthy, long life, according to this longevity expert
03.11.2023.
Business Insider
Whether pills, stem cell therapy or cryopreservation: For years, researchers have been looking for ways to extend our lives and keep us forever young. But according to longevity investor Marc Bernegger, you don't have to spend a ton of money or completely change your life to live longer than average. You can find out here which measures the longevity expert integrates into his own everyday life.
Longevity is set to become the dominant industry of our century
30.10.2023.
VentureCapital Magazin
The Swiss venture builder Maximon relies on the desire for the fountain of youth in its investments - but it's not just about investments in the beauty segment, but also about preventing age-related diseases.
The Business of Pills and Powders that are supposed to slow down Aging
04.10.2023.
Handelszeitung
Dietary supplements against aging are experiencing brisk sales. This was heard at the Longevity Investors Conference, which took place for the second time in Gstaad at the end of September 2023. Tobias Reichmuth (44), one of the initiators of the conference at the luxury hotel Le Grand Bellevue, reported on the industry's steep revenue growth in his opening speech.
